Gastrointestinal Disorders

Articles

There is a lot of new information about the link between various malignancies and inflammatory bowel disease. Here: answers to 3 key questions. 

The IBD-Cancer Link: 3 Key Questions

Diet diaries and food frequency questionnaires are both effective tools to capture important patterns between food items and symptoms of IBD.

Dietary Assessments Valuable for Crohn Disease Patients

IDA is commonly seen in IBD as a result of iron malabsorption and, ironically, chronic blood loss through disrupted mucosal surfaces.

Iron deficiency Anemia in IBD: These Patients Need Primary Care

Patients with UC who also have celiac disease may be at higher risk for pancolitis as opposed to more limited forms of inflammatory bowel disease.

Celiac Disease and Inflammatory Bowel Disease: Co-Occurrence Increases Pancolitis

The mechanisms and effectiveness of probiotics in treatment of irritable bowel syndrome and inflammatory bowel disease are emerging.

Probiotics: What Role, if Any, in the Management of IBS? IBD?

New insights into how clinicians might approach treatment for patients with IBD highlighted the recent Crohn’s & Colitis Foundation’s Clinical & Research Conference.

Inflammatory Bowel Disease Treatment Trends Highlighted at Conference

Podcasts

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

Clinical Tips for Using Antibiotics and Corticosteroids in IBD

New drugs are needed because a significant fraction of patients reach the end of the line with existing therapies.

New Inflammatory Bowel Disease Therapies in Development

All patients with IBD should receive aggressive ongoing assessment of their inflammatory state and its response to immunomodulators, anti-TNF drugs, and other agents.

Inflammatory Bowel Disease Treatment Monitoring Strategies

A purely dichotomous understanding of whether to start treatment for patients who have IBD with anti-TNF agents is becoming an outdated view.